机构：[1]Department of Oncology, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China临床科室肿瘤内科河北医科大学第四医院[2]Department of Pharmacology, Hebei Medical University, Shijiazhuang, China[3]Department of Pharmacology, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China药学部药学部河北医科大学第四医院
第一作者机构：[1]Department of Oncology, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China
推荐引用方式(GB/T 7714)：
Shi J.,Qi J.,Liang Y.,et al.Study on human plasma concentration and serosal permeation of oral apatinib mesylate[J].ANNALS OF ONCOLOGY.2020,31:S256-S256.doi:10.1016/j.annonc.2020.08.190.
APA：
Shi, J.,Qi, J.,Liang, Y.,Wang, L.,Huang, G....&Zhao, Y..(2020).Study on human plasma concentration and serosal permeation of oral apatinib mesylate.ANNALS OF ONCOLOGY,31,
MLA：
Shi, J.,et al."Study on human plasma concentration and serosal permeation of oral apatinib mesylate".ANNALS OF ONCOLOGY 31.(2020):S256-S256
医学